ArticleInternational cancer conference journal2025
Small cell bladder carcinoma with a high tumor mutational burden responding to sequential cisplatin-etoposide and pembrolizumab: a case report.
Akira Ohtsu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.